|
|
|
|
||
Re: annual meeting set for April 18th AND Is Flipper Flipping Apropos Huawei:- Huawei precision medicine cloud | A revolutionary step in the field of genomicsHuawei cloud services have over 50,000 customers spread throughout China with data centers in 15 cities. Leading the way in genomics technology and powering the leading population genomics with large-scale medicine efforts in UK, Qatar, US and China, Wuxi NextCODE is about to enter the cloud space through the Precision Medicine Cloud(PMC) powered by DNAnexus. DNAnexus provides security, scalability, and collaboration for enterprises and institutions that are pursuing genomic-based approaches to health to accelerate medical discovery. This initiative is to bring cloud-based genomics to China and to introduce Chinese genomics to the world. The cost associated with this action is estimated to be $9.2 Billion and is expected to touch almost 100 Million lives by 2030. China has enlisted the private sector as well as government resources in its dream to make the country a leader in “precision medicine,” which aims to treat diseases tailored to individual patients based on their genetic makeup. This Precision Medicine Cloud will expedite China’s bid to be the DNA superpower of the world. https://www.dr-hempel-network.com/digital-health-technolgy/huawei-precision-medicine-genomics/ And topically (though no direct Huawei link):- Chinese Scientists Sequence Genome of Covid-19 https://www.asianscientist.com/2020/02/topnews/china-coronavirus-covid-19-study/ https://journals.lww.com/cmj/Abstract/publishahead/Identification_of_a_novel_coronavirus_causing.99423.aspx Results: Five patients hospitalized from December 18 to December 29, 2019 presented with fever, cough, and dyspnea accompanied by complications of acute respiratory distress syndrome. Chest radiography revealed diffuse opacities and consolidation. One of these patients died. Sequence results revealed the presence of a previously unknown β-CoV strain in all five patients, with 99.8% to 99.9% nucleotide identities among the isolates. These isolates showed 79.0% nucleotide identity with the sequence of SARS-CoV (GenBank NC_004718) and 51.8% identity with the sequence of MERS-CoV (GenBank NC_019843). The virus is phylogenetically closest to a bat SARS-like CoV (SL-ZC45, GenBank MG772933) with 87.6% to 87.7% nucleotide identity, but is in a separate clade. Moreover, these viruses have a single intact open reading frame gene 8, as a further indicator of bat-origin CoVs. However, the amino acid sequence of the tentative receptor-binding domain resembles that of SARS-CoV, indicating that these viruses might use the same receptor. Conclusion: A novel bat-borne CoV was identified that is associated with severe and fatal respiratory disease in humans. The researchers then
constructed the whole genomic sequence of the new virus—now known as
COVID-19—and found that its genome sequence is 79 percent similar to the
SARS-CoV, about 51.8 percent similar to the MERS-CoV, and about
87.6-87.7 percent similar to other SARS-like CoVs from Chinese horseshoe
bats (called ZC45 and ZXC21). These findings clearly suggest that the
virus originated from bats. Read more from Asian Scientist Magazine at:
https://www.asianscientist.com/2020/02/topnews/china-coronavirus-covid-19-study/ Chinese Scientists
Sequence Genome Of COVID-19 Read more from Asian Scientist Magazine at:
https://www.asianscientist.com/2020/02/topnews/china-coronavirus-covid-19-study/ Chinese Scientists
Sequence Genome Of COVID-19 Read more from Asian Scientist Magazine at:
https://www.asianscientist.com/2020/02/topnews/china-coronavirus-covid-19-study/ Chinese Scientists
Sequence Genome Of COVID-19 Read more from Asian Scientist Magazine at:
https://www.asianscientist.com/2020/02/topnews/china-coronavirus-covid-19-study/ |
return to message board, top of board |